The addition of nutrients and accumulation of metabolites in a fed-batch culture of Chinese hamster ovary (CHO) cells leads to an increase in extracellular osmolality in late stage culture. Herein, we explore the effect of osmolality on CHO cell growth, specific monoclonal antibody (mAb) productivity and glycosylation achieved with the addition of NaCl or the supplementation of a commercial feed. Although both methods lead to an increase in specific antibody productivity, they have different effects on cell growth and antibody production. Osmolality modulation using NaCl up to 470 mOsm kg−1 had a consistently positive effect on specific antibody productivity and titre. The addition of the commercial feed achieved variable results: specific mAb productivity was increased, yet cell growth rate was significantly compromised at high osmolality values. As a result, Feed C addition to 410 mOsm kg−1 was the only condition that achieved a significantly higher mAb titre compared to the control. Additionally, Feed C supplementation resulted in a significant reduction in galactosylated antibody structures. Cell volume was found to be positively correlated to osmolality; however, osmolality alone could not account for observed changes in average cell diameter without considering cell cycle variations. These results help delineate the overall effect of osmolality on titre and highlight the potentially negative effect of overfeeding on cell growth.
High scientific output has made two Saudi universities perform well in academic ranking systems. The improvement in university ranking is generally observed in other indicators such as the innovation index, the abundance of cutting-edge research, and the number and success of patents and startups. In this paper, the impact of research output of highly cited researchers at two Saudi public universities is investigated from different standpoints and compared with international examples. Many citation databases, ranking systems and international indicators have been used in this paper to thoroughly discuss the research and development landscape in Saudi Arabia. Saudi public universities have the greatest number of highly cited researchers who mostly have another international affiliation. The Saudi academic patent number has increased dramatically since 2014, with minimum improvement in the country’s innovation and startups performance. Many of the Saudi highly cited papers are scattered in the literature with neither a specific targeted field nor follow-up studies. The role of the Saudi universities in industrial collaboration, technology advancement and economic prosperity is less than expected considering the Saudi position on the international stage. Entrepreneurship, innovation and research commercialisation ought to be supported by more private and public initiatives. Transparency, critical thinking, and accountability are needed the most in Saudi academic institutes. Recommendations are given for improving the research culture and following the best practice.
Monoclonal antibodies (mAbs) have been extensively studied for their wide therapeutic and research applications. Increases in mAb titre has been achieved mainly by cell culture media/feed improvement and cell line engineering to increase cell density and specific mAb productivity. However, this improvement has shifted the bottleneck to downstream purification steps. The higher accumulation of the main cell-derived impurities, host cell proteins (HCPs), in the supernatant can negatively affect product integrity and immunogenicity in addition to increasing the cost of capture and polishing steps. Mathematical modelling of bioprocess dynamics is a valuable tool to improve industrial production at fast rate and low cost. Herein, a single stage volume-based population balance model (PBM) has been built to capture Chinese hamster ovary (CHO) cell behaviour in fed-batch bioreactors. Using cell volume as the internal variable, the model captures the dynamics of mAb and HCP accumulation extracellularly under physiological and mild hypothermic culture conditions. Model-based analysis and orthogonal measurements of lactate dehydrogenase activity and double-stranded DNA concentration in the supernatant show that a significant proportion of HCPs found in the extracellular matrix is secreted by viable cells. The PBM then served as a platform for generating operating strategies that optimise antibody titre and increase cost-efficiency while minimising impurity levels.
Researchers are exploring plant-based protein sources to address both malnutrition and climate change. Desert truffles are rich in protein (i.e., 20%) and offer a cheaper and more environmentally friendly option. However, desert truffle cultivation is limited by environmental factors like rainfall and soil properties. This study was conducted to understand the soil conditions and microbiomes associated with desert truffles growing in parts of Saudi Arabia. Based on yield, the truffle fields were categorized into high-yield (50 kg/ha annually) and low-yield (2 kg/ha annually) truffle farms. Truffle yield differences were not significantly influenced by most soil physicochemical variables except for total nitrogen (negatively correlated). However, low soil nitrogen alone did not explain yield disparities, as wild truffle fields with low nitrogen also produced fewer truffles. In contrast, truffle yield showed a strong positive correlation with calcium carbonate content. We hypothesized that the unmeasured irrigation schedule was most likely behind the truffle yield differences especially during fruiting season. Furthermore, the high-yield farms had lower bacteria richness and diversity than the low-yield farms. Environmentally important bacteria genera such as Geodermatophilus and Rubrobacter were found in both farms, although more were found in the low-yield one, whereas more Streptomyces were found in the high-yield farm. In addition, fungal alpha diversity was higher in the high-yield farm with the dominance of Sordariomycetes, Dothideomycetes, Eurotiomycetes, and Glomeromycetes.
Therapeutic proteins, particularly monoclonal antibodies, represent a cutting-edge technology for combating chronic illnesses. These biomolecules are produced in cell-based expression systems that generate thousands of impurities, which must be removed through a sequence of chromatographic and filtration steps to ensure drug efficacy and patient safety. Host cell proteins (HCPs) are among the most concerning impurities, due to quantification challenges, their physicochemical diversity, and their potential to affect drug stability and increase immunogenicity. Tracking and removing HCPs remains a perpetual industrial goal and a growing topic of discussion in the biotechnology industry and amongst regulators. In this review, we provide a comprehensive overview of the research about HCPs in biopharmaceutical processes, highlighting gaps in process analytics, process design, and impurity risk assessment. We summarise the challenges and recent progress in HCP detection and quantification, with extensive focus on LC-MS workflows. We next examine methods to reduce HCPs in the upstream process, followed by an overview of emerging purification technologies. Finally, we review some experimental and computational tools for predicting product immunogenicity and optimising manufacturing processes. This review focuses on advances made in the past five years and is intended to support decision-making in therapeutic protein manufacturing.